Marilda Mormando Giulia Puliani Agnese Barnabei Rosa Lauretta Marta Bianchini Alfonsina Chiefari Michelangelo Russillo Francesco Cognetti Luisa Romano Marialuisa Appetecchia
10.3389/fendo.2020.00471
Front Endocrinol (Lausanne)
2020 Jul 23;11:471.
dabrafenib melanoma pituitary pituitary melanoma metastasis therapy trametinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/32793120/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Melanoma / drug therapy Pituitary Neoplasms / drug therapy Skin Neoplasms / drug therapy
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Melanoma / drug therapy Pituitary Neoplasms / drug therapy Skin Neoplasms / drug therapy Case Reports Adult Humans Imidazoles / administration & dosage Male Melanoma / genetics Melanoma / secondary Mutation Oximes / administration & dosage Pituitary Neoplasms / genetics Pituitary Neoplasms / pathology Prognosis Proto-Oncogene Proteins B-raf / genetics Pyridones / administration & dosage Pyrimidinones / administration & dosage Skin Neoplasms / genetics Skin Neoplasms / secondary Imidazoles Oximes Pyridones Pyrimidinones trametinib BRAF protein, human Proto-Oncogene Proteins B-raf dabrafenib
PMC7390838
32793120
A Rare Case of Pituitary Melanoma Metastasis: A Dramatic and Prolonged Response to Dabrafenib-Trametinib Therapy
2020